Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Preventing fractures—how good are we really?

Nature Clinical Practice Endocrinology & Metabolism volume 2, pages 606–607 (2006)Cite this article

boxed-textFeldstein A et al. (2006) Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc 54: 450–457

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kanis JA et al. (2002) Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30: 251–258

    Article  CAS  Google Scholar 

  2. Delmas PD (2002) Treatment of postmenopausal osteoporosis. Lancet 359: 2018–2026

    Article  CAS  Google Scholar 

  3. Caro JJ et al. (2004) The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 15: 1003–1008

    Article  Google Scholar 

  4. Recker RR et al. (2005) Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 80: 856–861

    Article  Google Scholar 

  5. Cooper A et al. (2006). Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study. Int J Clin Pract 60: 896–905

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Medicine at the University of Melbourne, Melbourne, Australia

    Ego Seeman

Authors
  1. Ego Seeman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ego Seeman.

Ethics declarations

Competing interests

Dr Seeman is a Medical Advisory Board member for GlaxoSmithKline, Merck Sharpe & Dohme, Novartis, Roche, Sanofi-Aventis, and Servier.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seeman, E. Preventing fractures—how good are we really?. Nat Rev Endocrinol 2, 606–607 (2006). https://doi.org/10.1038/ncpendmet0316

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0316

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing